Xiao-Yan He

Xiao-Yan He

Auto-generated profile, based on publicly available information

Xiao-Yan He

Nanfang Hospital Southern Medical University No. 1023, Shatai Road Guangzhou 510515 P.R. China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2017 in IEEE/ACM Transactions on Computational Biology and Bioinformatics
Verified
Journal Article
Open access
茜谢茜 谢
茜 谢
XHXiaoyan He
Xiaoyan He
FYFangji Yang
Fangji Yang
XLXuling Liu
Xuling Liu
YLYing Li
Ying Li
WZWei Zhao
Wei Zhao
The outbreak of Middle East respiratory syndrome-coronavirus (MERS-CoV) in South Korea in April 2015 led to 186 infections and 37 deaths by the end of October 2015. MERS-CoV was isolated from the imported patient in China. The envelope (E) protein, a small structural protein of MERS-CoV, plays an important role in host recognition and infection. To identify the conserved epitopes of the E protein, sequence analysis was performed by comparing the E proteins from 42 MERS-CoV strains that triggered severe pandemics and infected humans in the past. To predict the potential B cell epitopes of E protein, three most effective online epitope prediction programs, the ABCpred, Bepipred, and Protean programs from the LaserGene software were used. All the nucleotides and amino acids sequences were obtained from the NCBI Database. One potential epitope with a suitable length (amino acids 58-82) was confirmed and predicted to be highly antigenic. This epitope had scores of >0.80 in ABCpred and level 0.35 in Bepipred programs. Due to the lack of X-ray crystal structure of the E protein in the PDB database, the simulated 3D structure of the E protein were also predicted using PHYRE 2 and Pymol programs. In conclusion, using bioinformatics methods, we analyzed the genome sequence of MERS-CoV and identified a potential B-cell epitope of the E protein, which might significantly improve our current MERS vaccine development strategies.

1 March 2016
Verified
Journal Article
Closed access
XHXiao-Yan He
Xiao-Yan He
GZGuo-Zhong Zhang
Guo-Zhong Zhang
MLMingzhou Li
Mingzhou Li
GWGang Wang
Gang Wang
DLDan Liu
Dan Liu
WFWen-Feng Feng
Wen-Feng Feng